Transgenic mouse models of Alzheimer's disease: An integrative analysis

R Sanchez-Varo, M Mejias-Ortega… - International Journal of …, 2022 - mdpi.com
Alzheimer's disease (AD) constitutes the most prominent form of dementia among elderly
individuals worldwide. Disease modeling using murine transgenic mice was first initiated …

Factors associated with brain ageing-a systematic review

J Wrigglesworth, P Ward, IH Harding, D Nilaweera… - BMC neurology, 2021 - Springer
Background Brain age is a biomarker that predicts chronological age using neuroimaging
features. Deviations of this predicted age from chronological age is considered a sign of age …

Development of disease-modifying drugs for frontotemporal dementia spectrum disorders

F Panza, M Lozupone, D Seripa, A Daniele… - Nature Reviews …, 2020 - nature.com
Frontotemporal dementia (FTD) encompasses a spectrum of clinical syndromes
characterized by progressive executive, behavioural and language dysfunction. The various …

TDP-43-stratified single-cell proteomics of postmortem human spinal motor neurons reveals protein dynamics in amyotrophic lateral sclerosis

AJ Guise, SA Misal, R Carson, JH Chu, H Boekweg… - Cell reports, 2024 - cell.com
A limitation of conventional bulk-tissue proteome studies in amyotrophic lateral sclerosis
(ALS) is the confounding of motor neuron (MN) signals by admixed non-MN proteins. Here …

[HTML][HTML] TDP-43 and tau oligomers in Alzheimer's disease, amyotrophic lateral sclerosis, and frontotemporal dementia

M Montalbano, S McAllen, FL Cascio, U Sengupta… - Neurobiology of …, 2020 - Elsevier
Proteinaceous aggregates are major hallmarks of several neurodegenerative diseases.
Aggregates of post-translationally modified transactive response (TAR)-DNA binding protein …

Recent developments in clinical plasma proteomics—applied to cardiovascular research

NB Palstrøm, R Matthiesen, LM Rasmussen, HC Beck - Biomedicines, 2022 - mdpi.com
The human plasma proteome mirrors the physiological state of the cardiovascular system, a
fact that has been used to analyze plasma biomarkers in routine analysis for the diagnosis …

From multi-omics approaches to precision medicine in amyotrophic lateral sclerosis

G Morello, S Salomone, V D'Agata… - Frontiers in …, 2020 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a devastating and fatal neurodegenerative disorder,
caused by the degeneration of upper and lower motor neurons for which there is no truly …

Remodeling of astrocyte secretome in amyotrophic lateral sclerosis: uncovering novel targets to combat astrocyte-mediated toxicity

W Ng, SY Ng - Translational neurodegeneration, 2022 - Springer
Amyotrophic lateral sclerosis (ALS) is an adult-onset paralytic disease characterized by
progressive degeneration of upper and lower motor neurons in the motor cortex, brainstem …

The need for biomarkers in the ALS–FTD spectrum: a clinical point of view on the role of proteomics

F Vignaroli, A Mele, G Tondo, V De Giorgis, M Manfredi… - Proteomes, 2023 - mdpi.com
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are severely
debilitating and progressive neurodegenerative disorders. A distinctive pathological feature …

[HTML][HTML] Biomarkers in frontotemporal dementia: Current landscape and future directions

A Gifford, N Praschan, A Newhouse… - Biomarkers in …, 2023 - Elsevier
Frontotemporal dementia (FTD) is one of the most common neurodegenerative diseases,
encompassing a myriad of different, clinically distinct subtypes which all target the …